Acorda Therapeutics Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Acorda Therapeutics Inc.

An SI Board Since October 2003

Posts	SubjectMarks	Bans	Symbol
120	6	0	ACOR

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
120	Comparing Acor to Questcor will be needed before making a decision to buy as the	willygs512	-	6/30/2012
119	The earnings PR, available on the company's web site, has details on prescri	tnsaf	-	11/1/2010
118	ACOR has $12M profit on $63M sales. Nice margin growth since last quarterly rep	pgo-neil	-	11/1/2010
117	Acorda 2Q loss narrows on Ampyra sales 10:50 am ET 08/03/2010 - Associated Press	Arthur Radley	-	8/3/2010
116	Good news for ACOR - nerispirdine discontinued : Quote:Two projects in Phas	idos	-	4/29/2010
115	minyanville.com Excellent comments on ACOR---	Arthur Radley	-	4/14/2010
114	main.nationalmssociety.org NMSS comments on ACOR drug	Arthur Radley	-	2/17/2010
113	Just out of curiosity and with your professed ability for projections and you no	Arthur Radley	-	2/4/2010
112	It is just an opinion. You won't be the first to reject one of my opinions.	kenhott	2	2/4/2010
111	Like guiding to $5-10K and coming in at $9.9K :)	rkrw	-	2/4/2010
110	You mean like $5-10k and come in below 5k? I don't think I can remember one	kenhott	-	2/4/2010
109	Has a company ever come in at a price below expectations? The system is price	rkrw	-	2/4/2010
108	You know what? You win! I'm done posting here re ACOR. I know what the numb	quantman	-	2/4/2010
107	You read my posts??? Message 26002877 <I will add one more point. Companies	kenhott	3	2/4/2010
106	BS, this was NOT expected by the analysts who had all modeled it based on $8.5K/	quantman	-	2/3/2010
105	annual cost of $12,850 Acorda Therapeutics Announces Pricing and Patient Assist	kenhott	-	2/3/2010
104	I think maybe everyone should come up with his/her own personal views on sales l	kenhott	-	1/28/2010
103	Thanks so much, since you are on v/c. Have fun, and no need to reply until you a	quantman	-	1/27/2010
102	We are skiing and if I get caught working, the boss will kill me and I will be d	kenhott	-	1/27/2010
101	I don't know about the easy money already have been made part. Let's lo	quantman	-	1/26/2010
100	Thanks. I had rejection at 2% chance. Lucky for me I was not wrong. There are	kenhott	-	1/26/2010
99	Ampyra approved. Congrats to longs! Cheers, Tuck	tuck	-	1/22/2010
98	A few of those were mine. Getting into position for news tonight.	kenhott	-	1/22/2010
97	PDUFA date tomorrow. There was a fair amount of February and March option activ	tnsaf	-	1/21/2010
96	I think pretty much the market is giving no value for ACOR's pipeline. I th	kenhott	-	11/3/2009

Go to reply# or date (mm/dd/yy):